ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,036Medicare Part D Prescriptions Filled, Including Refills
$382K Total Retail Price of All Prescriptions
406 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 431 413
SERTRALINE HCL 410 401
OMEPRAZOLE 314 305
AMLODIPINE BESYLATE 312 304
SIMVASTATIN 286 275
CITALOPRAM HBR 267 266
DONEPEZIL HCL 249 249
LISINOPRIL 241 233
WARFARIN SODIUM 241 231
TRAZODONE HCL 236 231
NAMENDA 181 181
ATORVASTATIN CALCIUM 179 171
GABAPENTIN 171 160
METOPROLOL TARTRATE 162 145
FUROSEMIDE 141 136
POTASSIUM CHLORIDE 141 134
HYDROCODONE-ACETAMINOPHEN 134 131 S3
ATENOLOL 132 122
TRAMADOL HCL 128 112
ALENDRONATE SODIUM 123 123
MIRTAZAPINE 116 116
HYDROCHLOROTHIAZIDE 112 101
METOPROLOL SUCCINATE 109 107
LOSARTAN POTASSIUM 109 102
PRAVASTATIN SODIUM 94 91
ZOLPIDEM TARTRATE 92 90
CARVEDILOL 79 79
TAMSULOSIN HCL 77 77
METFORMIN HCL 74 67
RISPERIDONE 68 66
GLIPIZIDE ER 67 57
CARBIDOPA-LEVODOPA 63 63
ROPINIROLE HCL 61 61
GLIPIZIDE 59 59
OXYCODONE HCL 58 58 S2
QUETIAPINE FUMARATE 58 58
CLOPIDOGREL 56 56
ENALAPRIL MALEATE 55 55
ISOSORBIDE MONONITRATE ER 55 55
BENAZEPRIL HCL 54 54
SEROQUEL 54 53
POLYETHYLENE GLYCOL 3350 54 53
PANTOPRAZOLE SODIUM 53 53
FLUTICASONE PROPIONATE 52 52
ALLOPURINOL 51 51
ESCITALOPRAM OXALATE 50 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 28, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.